Lansons recruits Kate Aldous
Appointment boosts healthcare offering - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021
Search results
Found 346 pages
AUTHOR: George Underwood
Method Medical Media launches
London-based agency begins trading today - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/method_medical_media_launches_1204334Together as one - PharmaTimes Magazine June 2018
We caught up with IQVIA’s SVP global technology solutions, Tal Rosenberg, at the 2018 eyeforpharma Barcelona conference as the company announced the EU launch of its Orchestrated Customer Engagement product, which aims to harmonise pharma's interaction with customers - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/june_2018/together_as_oneFDA grants Keytruda priority review
If approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/fda_grants_keytruda_priority_review_1233852New general manager for Abbie UK
- Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/new_general_manager_for_abbie_uk_1195687Loud and clear - PharmaTimes Magazine January 2018
We asked the winning companies from the 2017 Communications Team of the Year competition what pharma’s comms priorities should be - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/januaryfebruary_2018/loud_and_clearBayer halts Xarelto trial
Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/bayer_halts_xarelto_trial_120703690TEN boosts PR division
New hires from Bisector 2 and Tonic - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/90ten_boosts_pr_division_1022156Review of the year 2016: M&A - PharmaTimes Magazine December 2016
Merger mania slowed but certainly didn't disappear in 2016 - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2016/december/review_of_the_year_2016_m_and_aNovartis' biosimilar rituximab delayed in US
Rejection is another win for drugs' originator Roche - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/novartis_biosimilar_rituximab_delayed_in_us_1234248
